Alex Bulychev

Alex Bulychev is a seasoned professional in the pharmaceutical industry with extensive experience in drug development and nonclinical support across various therapeutic areas, including oncology and gastrointestinal inflammation. Currently serving as a Scientific Director at Takeda, Alex has held significant positions at multiple leading organizations, including Director at Alltrna, Associate Director at Wave Life Sciences, and Principal Scientist at Moderna Therapeutics. Alex's background includes comprehensive work in preclinical development, particularly in PBPK modeling and drug candidate validation at Millennium Pharmaceuticals. Education credentials comprise a PhD in Chemistry from Wayne State University and post-doctoral training in Protein Chemistry/Sciences at UTHealth Houston.